Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: Acute and mid-term clinical and angiographic outcomes

Journal of Cardiovascular Medicine

Volumn 9, Issue 4, 2008, Pages 396-402

  Tarantini, Giuseppe ^a,b   Favaretto, Enrico ^a   Gardin, Arianna ^a   Napodano, Massimo ^a   Isabella, Gianbattista ^a   Panfili, Marco ^a   Gerosa, Gino ^a   Iliceto, Sabino ^a   Ramondo, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Allograft vasculopathy; Drug eluting stent; Percutaneous coronary intervention

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DISEASE COURSE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HOSPITAL PATIENT; HUMAN; MALE; OUTCOME ASSESSMENT; RECIPIENT; RESTENOSIS; REVASCULARIZATION; TREATMENT OUTCOME;

CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 40649103474     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3282ef4b3e     Document Type: Article

References (35)

1. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Deng MC, Keck BM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report - 2005. J Heart Lung Transplant 2005; 24:945-955.
2. Avery RK. Cardiac-allograft vasculopathy. N Engl J Med 2003; 349:829-830.
3. Costanzo MR, Naftel DC, Pritzker MR, Heilman JK 3rd, Boehmer JP, Brozena SC, et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 1998; 17:744-753.
4. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992; 11:S38-S44.
5. Kirklin JK, Young JB, McGiffin DC, Benza RL, Tallaj J. Cardiac allograft vasculopathy (chronic rejection). In: Kirklin JK, Young JB, McGiffin DC, editors. Heart transplantation. New York: Churchill Livingstone; 2002. pp. 615-665.
6. Weis M, von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 1997; 96:2069-2077.
7. Melnick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA 1990; 263:2204-2207.
8. Gao SZ, Schroeder JS, Hunt S, Stinson EB. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol 1988; 62:876-881.
9. Stevenson LW, Warner SL, Steimle AE, Fonarow GC, Hamilton MA, Moriguchi JD, et al. The impending crisis awaiting cardiac transplantation. Modeling a solution based on selection. Circulation 1994; 89:450-457.
10. Parry A, Roberts M, Parameshwar J, Wallwork J, Schofield P, Large S. The management of post-cardiac transplantation coronary artery disease. Eur J Cardiothorac Surg 1996; 10:528-532.
11. Johnson DE, Alderman EL, Schroeder JS, Gao SZ, Hunt S, DeCampli WM, et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol 1991; 17:449-457.
12. Schoen FJ, Libby P. Cardiac transplant graft arteriosclerosis. Trends Cardiovasc Med 1991; 1:216-223.
13. Benza RL, Zoghbi GJ, Tallaj J, Brown R, Kirklin JK, Hubbard M, et al. Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience. J Am Coll Cardiol 2004; 43:1973-1981.
14. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-1323.
15. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al., TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108:788-794.
16. MoriceMC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al., RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-1780.
17. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al., TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350:221-231.
18. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al., TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004; 109:1942-1947.
19. Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 1988; 12:334-340.
20. Popma JJ, Bashore TD. Qualitative and quantitative angiography. In: Topol E, editor. Textbook of interventional cardiology. Philadelphia: WB Saunders; 1994. pp. 1052-1068.
21. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003; 107:2178-2180.
22. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kerejakes DJ, Kern MJ, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines) - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 2001; 37:2215-2239.
23. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130.
24. Keogh AM, Valantine HA, Hunt SA, Schroeder JS, McIntosh N, Oyer PE, et al. Impact of proximal or midvessel discrete coronary artery disease on survival after heart transplantation. J Heart Lung Transplant 1992; 11:892-901.
25. Seydoux C, Berguer DG, Eeckhout E, Stumpe F, Hurni M, Ruchat P, et al. Coronary stenting for coronary artery narrowing in a heart transplant recipient. Transpl Int 1996; 9:433-436.
26. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al., Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331:496-501.
27. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al., Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331:489-495.
28. Von Scheidt V, Uberfuhr P, Reichart B, Steinbeck G. The role of PTCA in the management of focal critical lesions in transplant coronary artery disease. Transplant Proc 1995; 27:1936-1938.
29. Halle AA 3rd, Di Sciascio G, Massin EK, Wilson RF, Johnson MR, Sullivan HJ, et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 1995; 26:120-128.
30. Wong PM, Piamsomboon C, Mathur A, Chastain HD 2nd, Singh DJ, Liu MW, et al. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. Am J Cardiol 1998; 82:239-241.
31. Bader FM, Kfoury AG, Gilbert EM, Barry WH, Humayun N, Hagan ME, et al. Percutaneous coronary interventions with stents in cardiac transplant recipients. J Heart Lung Transplant 2006; 25:298-301.
32. Iofina E, Haager PK, Radke PW, Langenberg R, Blindt R, Ortlepp J, et al. Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis. Catheter Cardiovasc Interv 2005; 64:28-34.
33. Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003; 108:48-53.
34. Eisen HJ, Tuzcu EM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349:847-858.
35. Rahmani M, Cruz RP, Granville DJ, McManus BM. Allograft vasculopathy versus atherosclerosis. Circ Res 2006; 99:801-815.